Back to MORGAN STANLEY MORGAN STANLEY

ANABANAB
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ANAPTYSBIO INC

MORGAN STANLEY holds 257,091 shares of ANAB (ANAPTYSBIO INC), worth $17.4M as of 2026-Q2. The position was decreased (-74.1% shares). ANAB represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$17.4M

Current Shares

257,091

Total Value Change

+$11.4M

Total Shares Change

+79,709

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
257,091
-74.1%
$17.4M0.0%$67.50
0
2026-Q1
Decreased
993,905
-3.9%
$55.1M0.0%$52.83
0
2025-Q4
Decreased
1M
-33.5%
$50.2M0.0%$48.23
0
2025-Q3
Decreased
1.6M
-16.8%
$47.7M0.0%$23.27
0
2025-Q2
Increased
1.9M
+270.5%
$41.5M0.0%$22.47
47
2025-Q1
Increased
504,636
+133.7%
$9.4M0.0%$18.95
45
2024-Q4
Increased
215,917
+21.7%
$2.9M0.0%$13.22
32
2024-Q3
Increased
177,382
+93.3%
$5.9M0.0%$31.87
43

Other major holders of ANAB: ADAGE CAPITAL PARTNERS GP, L.L.C., BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used